Table 1.
Main characteristics of patients with or without CMV replication/disease in the first year after transplantation.
| CMV within the First Year | NO CMV within the First Year | p-Value | |
|---|---|---|---|
| Donor characteristics | |||
| Hypertension, % | 57.2 | 46.5 | 0.01 |
| Diabetes mellitus, % | 10.2 | 7.8 | 0.33 |
| Donor age ≥ 60 yrs, % | 62.4 | 46.4 | <0.01 |
| Median donor age (25th–75th percentiles) | 66 yrs (53.5–72) | 58 yrs (46–69) | <0.01 |
| Median donor eGFR CKD-EPI mL/min/1.73 m2/1.73 m2 (interquartile range) | 92.44 (68.89–104.35) | 93.00 (72.35–110.82) | 0.21 |
| Recipient characteristics | |||
| M/F ratio, % | 66.9/33.1 | 64.3/35.7 | 0.55 |
| Median age (25th–75thpercentiles) | 58 yrs (49; 65) | 54 yrs (46; 63) | 0.01 |
| HD/PD, % | 70.6/29.4 | 78.9/21.1 | 0.02 |
| Hypertension, % | 91 | 87 | 0.16 |
| Pre-Tx cardiopathy, % | 40.0 | 33.2 | 0.10 |
| Pre-Tx HCV+, % | 2.3 | 6.1 | 0.06 |
| Pre-Tx diabetes mellitus, % | 14.4 | 11.1 | 0.25 |
| Transplant characteristics | |||
| DR 0/1/2 (match), % | 0/64.6/35.4 | 0/54/45.9 | 0.03 |
| Cold ischemia ≥ 18 h, % | 57.2 | 49.4 | 0.04 |
| Delayed graft function, % | 28.7 | 24.7 | 0.29 |
| ATG induction therapy, % | 1.2 | 0.9 | 0.31 |